Handelsbanken Fonder AB »

Cerevel Therapeutics Hldng I shares owned by Handelsbanken Fonder AB

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Handelsbanken Fonder AB from 13F filings

Historical chart of Handelsbanken Fonder AB investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Handelsbanken Fonder AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Handelsbanken Fonder AB

Quarter filed Position value Share count Share price at filing
2023-12-31 $687k 16k 42.41
2023-09-30 $253k 12k 21.81
2023-06-30 $369k 12k 31.81
2023-03-31 $220k 9.0k 24.44
2022-12-31 $284k 9.0k 31.56
2022-09-30 $254k 9.0k 28.22
2022-06-30 $230k 8.7k 26.44
2022-03-31 $361k 10k 35.05
2021-12-31 $334k 10k 32.43